RCEL Live signals | Maximize Profits with Getagraph.com

SELL 95276 min ago

@ $17.14

Issued: 13 Feb 2024 @ 15:41

Return: -49.59%

Previous signal: Feb 12 - 13:54

Previous signal: Buy

Return: 0.06 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	367 693
Average Volume	221 319
Market Cap	222.11M
EPS	$0 ( 2024-02-22 )
Next earnings date	( $-0.260 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.17
ATR14	$0.0170 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	O'toole David D	Buy	250	Common Stock
2024-02-28	O'toole David D	Buy	1 000	Common Stock
2024-01-03	Shiroma Donna	Buy	100 000	Stock Options (Right to Buy)
2023-11-30	Shiroma Donna	Buy	1 469	Common Stock
2024-01-03	O'toole David D	Buy	125 000	Stock Options (Right to Buy)

INSIDER POWER
72.37
Last 97 transactions
Buy: 1 597 984 \| Sell: 352 272

Volume Correlation

Long: -0.20 (neutral)

Short: 0.24 (neutral)

Signal:(65.204) Neutral

Avita Therapeutics Inc Correlation

10 Most Positive Correlations
LWAC	0.956
NSIT	0.948
SJ	0.935
SRAC	0.93
MCAA	0.929
AMRB	0.929
TZPS	0.927
USAP	0.924
COCO	0.923
BIOT	0.922

10 Most Negative Correlations
SVAC	-0.949
FRBK	-0.94
AROW	-0.937
BCBP	-0.93
BWB	-0.926
GSMG	-0.921
DSWL	-0.92
ESPR	-0.919
VGFC	-0.918
FVCB	-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avita Therapeutics Inc Correlation - Currency/Commodity

0.38
( neutral )

0.39
( neutral )

0.00
( neutral )

0.51
( weak )

-0.65
( moderate negative )

-0.41
( neutral )

Avita Therapeutics Inc Financials

Annual	2022
Revenue:	$34.42M
Gross Profit:	$28.38M (82.45 %)
EPS:	$-1.070

Q3	2023
Revenue:	$13.65M
Gross Profit:	$11.53M (84.51 %)
EPS:	$-0.340

Q2	2023
Revenue:	$11.75M
Gross Profit:	$9.55M (81.25 %)
EPS:	$-0.410

Q1	2023
Revenue:	$10.55M
Gross Profit:	$8.88M (84.20 %)
EPS:	$-0.370

Financial Reports:

No articles found.

Avita Therapeutics Inc

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.